Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV)

被引:9
作者
Pezzoni, Giulia [1 ]
Stercoli, Lidia [1 ]
Pegoiani, Eleonora [1 ]
Brocchi, Emiliana [1 ]
机构
[1] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Via Bianchi 9, I-25124 Brescia, Italy
来源
VIRUSES-BASEL | 2021年 / 13卷 / 07期
关键词
HEV; monoclonal antibodies; recombinant antigens; HEV ORF2; MONOCLONAL-ANTIBODIES; CAPSID PROTEIN; IDENTIFICATION; IMMUNODOMINANT; NEUTRALIZATION; EPITOPES; PARTICLES; INFECTION; VIROLOGY; SITES;
D O I
10.3390/v13071385
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To evaluate the antigenic properties of Hepatitis E Virus (HEV) Open Reading Frame 2 and 3 (ORF2 and ORF3) codified proteins, we expressed different portions of ORF2 and the entire ORF3 in E. coli, a truncated ORF2, was also expressed in baculovirus. A panel of 37 monoclonal antibodies (MAbs) was raised against ORF2 (1-660 amino acids) and MAbs were mapped and characterized using the ORF2 expressed portions. Selected HEV positive and negative swine sera were used to evaluate ORF2 and ORF3 antigens' immunogenicity. The MAbs were clustered in six groups identifying six antigenic regions along the ORF2. Only MAbs binding to the sixth ORF2 antigenic region (394-608 aa) were found to compete with HEV positive sera and efficiently catch the recombinant antigen expressed in baculovirus. The ORF2 portion from 394-608 aa demonstrated to include most immunogenic epitopes with 85% of HEV positive swine sera reacting against the region from 461-544 aa. Only 5% of the selected HEV sera reacted against the ORF3 antigen.
引用
收藏
页数:15
相关论文
共 35 条
[1]   Development of new hepatitis E vaccines [J].
Cao, Yufeng ;
Bing, Zhenhong ;
Guan, Shiyu ;
Zhang, Zecai ;
Wang, Xinping .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) :2254-2262
[2]  
Chen YY, 2018, J VIROL, V92, DOI [10.1128/JVI.00251-18, 10.1128/jvi.00251-18]
[3]   Update on hepatitis E virology: Implications for clinical practice [J].
Debing, Yannick ;
Moradpour, Darius ;
Neyts, Johan ;
Gouttenoire, Jerome .
JOURNAL OF HEPATOLOGY, 2016, 65 (01) :200-212
[4]   Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy [J].
Donnelly, M. C. ;
Scobie, L. ;
Crossan, C. L. ;
Dalton, H. ;
Hayes, P. C. ;
Simpson, K. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (02) :126-141
[5]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[6]   Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity [J].
He, Junkun ;
Kuschner, Robert A. ;
Dewar, Vincent ;
Voet, Pierre ;
Asher, Ludmila V. ;
Vaughn, David W. .
JOURNAL OF BIOMEDICAL SCIENCE, 2007, 14 (05) :555-563
[7]   Characterization of Hepatitis E Virus Recombinant ORF2 Proteins Expressed by Vaccinia Viruses [J].
Jimenez de Oya, Nereida ;
Escribano-Romero, Estela ;
Blazquez, Ana-Belen ;
Lorenzo, Maria ;
Martin-Acebes, Miguel A. ;
Blasco, Rafael ;
Saiz, Juan-Carlos .
JOURNAL OF VIROLOGY, 2012, 86 (15) :7880-7886
[8]   IMMUNODOMINANT ANTIGENIC REGIONS IN A STRUCTURAL PROTEIN OF THE HEPATITIS-E VIRUS [J].
KHUDYAKOV, YE ;
FAVOROV, MO ;
JUE, DL ;
HINE, TK ;
FIELDS, HA .
VIROLOGY, 1994, 198 (01) :390-393
[9]   EPITOPE MAPPING IN PROTEINS OF HEPATITIS-E VIRUS [J].
KHUDYAKOV, YE ;
KHUDYAKOVA, NS ;
FIELDS, HA ;
JUE, D ;
STARLING, C ;
FAVOROV, MO ;
KRAWCZYNSKI, K ;
POLISH, L ;
MAST, E ;
MARGOLIS, H .
VIROLOGY, 1993, 194 (01) :89-96
[10]   INCIDENCE AND SEVERITY OF VIRAL-HEPATITIS IN PREGNANCY [J].
KHUROO, MS ;
TELI, MR ;
SKIDMORE, S ;
SOFI, MA ;
KHUROO, MI .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (02) :252-255